These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 38127213)
1. Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study. Gertsen EC; van der Veen A; Brenkman HJF; Brosens LAA; van der Post RS; Verhoeven RHA; Luijten JCHBM; Vissers PAJ; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP Ann Surg Oncol; 2024 Mar; 31(3):1760-1772. PubMed ID: 38127213 [TBL] [Abstract][Full Text] [Related]
2. The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients. Lu M; Yang Z; Feng Q; Yu M; Zhang Y; Mao C; Shen L; Tang J Medicine (Baltimore); 2016 Jul; 95(27):e4052. PubMed ID: 27399088 [TBL] [Abstract][Full Text] [Related]
3. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study. Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ? Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243 [TBL] [Abstract][Full Text] [Related]
5. Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges. Kumar NAN; Jose A; Usman N; Rajan K; Munisamy M; Shetty PS; Rao M Langenbecks Arch Surg; 2022 Feb; 407(1):87-98. PubMed ID: 34505199 [TBL] [Abstract][Full Text] [Related]
6. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107 [TBL] [Abstract][Full Text] [Related]
7. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country. Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903 [TBL] [Abstract][Full Text] [Related]
8. The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma. van Hootegem SJM; Smithers BM; Gotley DC; Brosda S; Thomson IG; Thomas JM; Gartside M; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; Barbour AP Ann Surg Oncol; 2019 Aug; 26(8):2375-2384. PubMed ID: 30941657 [TBL] [Abstract][Full Text] [Related]
9. Survival impact of gastrectomy and chemotherapy on gastric signet ring-cell carcinoma with different metastatic lesions: A population-based study. Ji J; Zhang X; Yuan S; Liu H; Yang L Asian J Surg; 2024 Apr; 47(4):1769-1775. PubMed ID: 38302357 [TBL] [Abstract][Full Text] [Related]
10. Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy. Tian S; Jiang R; Madden NA; Ferris MJ; Buchwald ZS; Xu KM; Cardona K; Maithel SK; McDonald MW; Lin JY; Curran WJ; El-Rayes BF; Behera M; Patel PR Cancer; 2020 Jan; 126(1):37-45. PubMed ID: 31532544 [TBL] [Abstract][Full Text] [Related]
11. Predictors of Lymph Node Metastasis and Differences Between Pure and Mixed Histologic Types of Early Gastric Signet-ring Cell Carcinomas. Chu Y; Mao T; Li X; Jing X; Ren M; Huang Z; Zhou XB; Chen Y; Tian Z Am J Surg Pathol; 2020 Jul; 44(7):934-942. PubMed ID: 32149737 [TBL] [Abstract][Full Text] [Related]
12. Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro-esophageal junction from a tertiary cancer care center in India. Rao T S; Raju KVVN; Patnaik SC; Reddy P; Saksena AR; Rajappa S; Mallavarapu KM; Santa A; Gudipudi D; Boleneni N; Usofi Z; Gujjuru S; Smith L; Are C; Nusrath S J Surg Oncol; 2021 Jun; 123(7):1547-1557. PubMed ID: 33650697 [TBL] [Abstract][Full Text] [Related]
14. Signet ring cell component, not the Lauren subtype, predicts poor survival: an analysis of 198 cases of gastric cancer. de Aguiar VG; Segatelli V; Macedo ALV; Goldenberg A; Gansl RC; Maluf FC; Usón Junior PLS Future Oncol; 2019 Feb; 15(4):401-408. PubMed ID: 30620220 [TBL] [Abstract][Full Text] [Related]
15. Prediction of lymph node metastasis in early gastric signet-ring cell carcinoma: A real-world retrospective cohort study. Yang JJ; Wang XY; Ma R; Chen MH; Zhang GX; Li X World J Gastroenterol; 2023 Jun; 29(24):3807-3824. PubMed ID: 37426318 [TBL] [Abstract][Full Text] [Related]
16. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands. Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917 [TBL] [Abstract][Full Text] [Related]
17. The percentages of signet-ring cells (SRCs) affects the prognosis after radical gastrectomy for advanced gastric cancer. Ma Y; Wang Y; Hu C; Zi M; Chen J; Cao M; Yuan L; Yang L; Du Y Langenbecks Arch Surg; 2023 Sep; 408(1):376. PubMed ID: 37743407 [TBL] [Abstract][Full Text] [Related]
18. Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study. Lam R; Tarangelo N; Wang R; Horibe M; Grimshaw AA; Jain D; Haffar S; Bazerbachi F; Kunz PL; Li DK Oncologist; 2022 Sep; 27(9):751-759. PubMed ID: 35589098 [TBL] [Abstract][Full Text] [Related]
19. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry. Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366 [TBL] [Abstract][Full Text] [Related]
20. Nodal downstaging to ypN0 after neoadjuvant chemotherapy positively impacts on survival of cT4N+ GC/GEJ patients. Wu L; Xing Z; Huang M; Yu H; Qin Y; Jin Q; Zhou Z; Chen J J Surg Oncol; 2022 Dec; 126(8):1403-1412. PubMed ID: 36001384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]